Today I had the pleasure of chairing and moderating a pivotal keynote panel discussion on 'Ways that AI can transform Market Access' at the Word Evidence Pricing & Access conference in Amsterdam. Joined by a dynamic group of industry leading experts as well as the payer and provider sector, we delved into the transformative potential of AI across the market access value chain. The depth of knowledge and range of perspectives shared were truly enlightening. Key Highlights: - Use cases along the market access value chain: The discussion spanned an array of use cases, from patient subgroup identification, AI-aided RWE data collection, to HE modelling, dossier writing and all the way to pricing predictive analytics and outcomes management. - Organization and data privacy: The group discussed the critical skills and rapidly evolving requirements for professionals working at the intersection of AI and market access (“You don’t get replaced by AI, but by people using AI”). Navigating data privacy and ethical considerations when using AI are critical too. - Building momentum: Going from use case to scale will likely include both, smaller pilots that can build short-term learnings across the organization with minimal disruption to the business, as well as use cases with longer-term objectives that are potentially more transformational. Undeniably, AI is set to revolutionize parts of the market access value chain. A big thank you to our panelists and the audience for engaging in such a forward-thinking conversation. Rogerio RibeiroSaira A. JanAlexander Bastian Chris Mancill
Generative AI can always make more of the same and recompose known material but is inherently relying on what it has seen/learned before in its training set. So aiding in putting together the scaffold of a HTA is one thing, but things get complicated when you want to defend synthetic patient data as replacement of real patient data - be it in the comparator arm or not 🤔 the question will be if “mixing in” partially synthetic arms will become the norm. Or rather, when
Chris Mancill
7mo
Thank you for having me on this exceptional panel, Cesaro. We are on the precipice of big changes that will power market access for the next decade and beyond.
Vicky Brigo
7mo
Congratulations again Sandro Cesaro - great panel and discussion! I left with lots of insights and feeling inspired.
Jessica Nora
7mo
Great transformation example.
Very interesting Sandro Cesaro thank you for sharing. Check this out Avisek Ghose
Claire Woon
7mo
Thanks for leading the discussion - some great food for thought!
Mark Seidler
7mo
Great opportunity to share experienc on an important topic!
Curious to hear more about this, Sandro!
Paola Valinotti
7mo
Insightful panel discussion Sandro Cesaro !
Global Head Digital Precision Healthcare @AstraZeneca
7moReally interesting topic ! Bravo